The development of cancer is due to loss of homeostasis between cell proliferation and cell death. Whilst it has been evident for some time that uncontrolled proliferation occurs in transformed cells, the lack of appropriate cell death is possibly of equal importance. Thus up-regulation of genes that inhibit tumour cells to promote their survival and continued growth. In recent years it has become evident that many cytotoxic agents can induced apoptosis through a number of different pathways that overlap to a greater or less extent, and finally converge on a common set of mediators, a series of proteases called caspases. Proteins that can inhibit one or more pathways of apoptosis have been identified, and some of these are over-expressed in tumour cells. The Bcl-2 homologues and the IAP family of proteins are the two best characterized groups of mammalian apoptosis inhibitors. It is proposed here that heat shock protein 72 (HSP72) can also function as an anti-apoptosis gene and evidence to support this statement is given. It is the aim of this project to determine the range of cytotoxic agents for which HSP72 shows protection and to establish the way in which HSP72 achieves this inhibition of cell death. Using a number of different cell lines expressing varying levels of HSP72, a series of experiments that will achieve this aim will be completed. It is also evident that other inhibitor proteins exist in cells and these may also be exploited by tumours to gain a survival advantage. In part 2 of this project, a screen of a cDNA library will be done to seek novel anti-apoptosis genes. The results of these studies should provide the knowledge required for the development of therapeutic strategies for tumours that develop resistance to apoptosis.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA081421-02
Application #
6174377
Study Section
Radiation Study Section (RAD)
Program Officer
Pelroy, Richard
Project Start
1999-09-30
Project End
2002-09-29
Budget Start
2000-09-30
Budget End
2001-09-29
Support Year
2
Fiscal Year
2000
Total Cost
$85,527
Indirect Cost
Name
Peter Maccallum Cancer Centre
Department
Type
DUNS #
City
East Melbourne
State
Country
Australia
Zip Code
3172
Steel, Rohan; Cross, Ryan S; Ellis, Sarah L et al. (2012) Hsp70 architecture: the formation of novel polymeric structures of Hsp70.1 and Hsc70 after proteotoxic stress. PLoS One 7:e52351
Cheng, Lesley; Smith, Danielle J; Anderson, Robin L et al. (2011) Human neuroblastoma SH-SY5Y cells show increased resistance to hyperthermic stress after differentiation, associated with elevated levels of Hsp72. Int J Hyperthermia 27:415-26
Cheng, Lesley; Smith, Danielle J; Anderson, Robin L et al. (2011) Modulation of cellular Hsp72 levels in undifferentiated and neuron-like SH-SY5Y cells determines resistance to staurosporine-induced apoptosis. PLoS One 6:e24473
Chow, Ari M; Steel, Rohan; Anderson, Robin L (2009) Hsp72 chaperone function is dispensable for protection against stress-induced apoptosis. Cell Stress Chaperones 14:253-63
Sun, Yunjuan; Ouyang, Yi-Bing; Xu, Lijun et al. (2006) The carboxyl-terminal domain of inducible Hsp70 protects from ischemic injury in vivo and in vitro. J Cereb Blood Flow Metab 26:937-50
Clemons, N J; Anderson, R L (2006) TRAIL-induced apoptosis is enhanced by heat shock protein 70 expression. Cell Stress Chaperones 11:343-55
Song, Keli; Benhaga, Nordine; Anderson, Robin L et al. (2006) Transduction of tumor necrosis factor-related apoptosis-inducing ligand into hematopoietic cells leads to inhibition of syngeneic tumor growth in vivo. Cancer Res 66:6304-11
Clemons, Nicholas J; Buzzard, Katherine; Steel, Rohan et al. (2005) Hsp72 inhibits Fas-mediated apoptosis upstream of the mitochondria in type II cells. J Biol Chem 280:9005-12
Steel, Rohan; Doherty, Judith P; Buzzard, Katherine et al. (2004) Hsp72 inhibits apoptosis upstream of the mitochondria and not through interactions with Apaf-1. J Biol Chem 279:51490-9